Average Co-Inventor Count = 4.25
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Kalvista Pharmaceuticals Limited (4 from 23 patents)
2. Asceneuron Sa (4 from 19 patents)
8 patents:
1. 12398130 - Acid addition salts of piperazine derivatives
2. 12195455 - Succinate and fumarate acid addition salts of piperazine derivatives
3. 11739068 - Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof
4. 11591327 - Acid addition salts of piperazine derivatives
5. 11584735 - Solid forms of a plasma kallikrein inhibitor and salts thereof
6. 11230537 - Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors
7. 10752607 - Polymorphs of N-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors
8. 10696668 - Acid addition salts of piperazine derivatives